Reagent Technology Licensed to Olympus Diagnostica

The waves induce quasi-chaotic streaming patterns that lead to the efficient agitation of liquids with volumes ranging from several hundred microliters down to a few nanoliters. The agitation method is noninvasive and prevents the risks of cross-contamination and carry-over. SAW technology has been commercially available in a hybridization station of Advalytix called SlideBooster, targeted at the research and development market. Now SAW will be introduced to the diagnostics market.

Olympus Diagnostica will integrate the technology into its product line of routine laboratory analyzers. "This technology will enable Olympus Diagnostica to significantly improve the next generation of analyzers,” noted Dr. Helmut Kohler, CEO of Olympus Diagnostica. Olympus Diagnostica is a systems provider for in vitro diagnostics in clinical chemistry, electrophoresis, and transfusion testing. Under the terms of the agreement, Olympus Diagnostica will provide an upfront payment, milestone payments, and royalties on the sales of instruments.



Related Links:
Olympus Diagnostica
Advalytix